Fig. 1From: Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CTSerum PSA value of a 78 years old patient with prostate adenocarcinoma falled to 0.33 ng/ml from 5476 ng/ml (a) after leuprolide + docetaxel therapy regimen. A significant regression in the lesions of prostate gland, bilateral lungs, lymph nodes and bones is seen after on [68Ga]Ga-PSMA-11 PET/CT images following therapy (b)Back to article page